BioSpace News Archive

Pursuit Vascular, Inc., manufacturer of ClearGuard® HD Antimicrobial Barrier Caps, announced it will be exhibiting at this week’s National Renal Administrators Association 2019 Annual Conference.

Astellas Pharma US, Inc. announced the finalists for its fourth annual C3 Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones.

4C Medical Technologies, Inc., the creator of a new generation of therapies for structural heart disease, announced that its medical device therapy for mitral regurgitation, AltaValve™, was featured at Transcatheter Cardiovascular Therapeutics 2019, on Sept 25-29 in San Francisco, CA.

ACUVUE™ RevitaLens MPDS Delivers Exceptional Contact Lens Disinfection and All-Day Comfort [30-September-2019] JACKSONVILLE, Fla. , Sept. 30, 2019 /PRNewswire/ -- Johnson & Johnson Vision † is excited to unveil the first-ever extension of the ACUVUE ® brand name beyond contact lenses with today’s launch of ACUVUE™ RevitaLens Multi-Purpose Disinfecting Solution (MP

Lipocine Inc. announced that the first patient has been dosed in its LiFT Phase 2 clinical study, a paired-biopsy study in confirmed pre-cirrhotic non-alcoholic steatohepatitis subjects.

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it will release its financial results for the third quarter of 2019 before the market opens on Wednesday, October 23, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT.

Boehringer Ingelheim announced that in the Phase III INBUILD® trial Ofev® slowed lung function decline by 57% across the overall study population, as assessed by the annual rate of decline in forced vital capacity over 52 weeks in patients with fibrosing interstitial lung diseases with signs of progression.

Actinium to highlight its Iomab-ACT program for targeted lymphodepletion for CAR-T and other adoptive cell therapies

Evotec SE and Indivumed GmbH announced that the first milestone has been successfully achieved in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer.

YuJa Inc. formally announces a partnership with Philadelphia College of Osteopathic Medicine to provide a campus-wide lecture capture system and video management solution to both their Philadelphia and Suwanee campuses.